Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03695380
Title A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

endometrioid ovary carcinoma

ovarian serous carcinoma

fallopian tube cancer

peritoneum cancer

Therapies

Atezolizumab + Cobimetinib + Niraparib

Cobimetinib + Niraparib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
University of Arizona Cancer Center, North Completed Tucson Arizona 85719 United States Details
Moores Cancer Center at UC San Diego Health Completed La Jolla California 92093 United States Details
Sutter Health Withdrawn San Francisco California 94109 United States Details
Mayo Clinic-Jacksonville Completed Jacksonville Florida 32224 United States Details
Florida Hospital Cancer Institute; Clinical Research Department Recruiting Orlando Florida 32804 United States Details
Medical College of Georgia; Obstetrics & Gynecolog Completed Augusta Georgia 30912-3335 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Withdrawn Baltimore Maryland 21287 United States Details
Washington University School of Medicine; Dept of Medicine/Div of Medical Oncology Recruiting Saint Louis Missouri 63108 United States Details
Columbia University Medical Center Withdrawn New York New York 10032 United States Details
Stephenson Cancer Center Investigational Pharmacy Completed Oklahoma City Oklahoma 73104 United States Details
Jordan Center for Gynecologic Cancers Withdrawn Philadelphia Pennsylvania 19104 United States Details
Tennessee Oncology; Sarah Cannon Research Institute Completed Nashville Tennessee 37203 United States Details
VCU Massey Cancer Center, Dalton Oncology Clinic Withdrawn Richmond Virginia 23298 United States Details
Medical College of Wisconsin; Department of Obstetrics and Gynecology Completed Milwaukee Wisconsin 53226 United States Details
Institut Bergonié Centre Régional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest Withdrawn Bordeaux 33076 France Details
Hopital Europeen Georges Pompidou; Service D'Oncologie Medicale Withdrawn Paris 75908 France Details
Centre Hospitalier Lyon Sud Withdrawn Pierre Benite 69495 France Details
Istituto Nazionale Tumori Fondazione G. Pascale Recruiting Napoli Campania 80131 Italy Details
Fondazione Policlinico Universitario "A. Gemelli"; Unità di Fase 1: Unità di Farmacologia Clinica Completed Rome Lazio 00168 Italy Details
Istituto Nazionale dei Tumori; Divisione Oncologia Chirurgica e Ginecologica Withdrawn Milano Lombardia 20133 Italy Details
Istituto Europeo di Oncologia; Svil. Nuovi Farmaci per Terapie Innovative Completed Milano Lombardia 20141 Italy Details
Centro Oncologico de Galicia COG; Medical Oncology Completed A Coruna LA Coruña 15009 Spain Details
Hospital Universitari Vall dHebron; Oncology Not yet recruiting Barcelona 08035 Spain Details
ICO Girona Completed Girona 17007 Spain Details
Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia Recruiting Jaen 23007 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Oncología Completed Madrid 28027 Spain Details
Hospital Ramon y Cajal; Servicio de Oncologia Completed Madrid 28034 Spain Details
Hospital Clinico San Carlos; Servicio de Oncologia Completed Madrid 28040 Spain Details
Hospital Clínico Universitario de Valencia; Servicio de Oncología Recruiting Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field